Onderneming Cerevel Therapeutics Holdings, Inc.
Aandelen
CERE
US15678U1280
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
42,14 USD | +1,30% | +0,31% | -0,61% |
Vakgebied
Aantal werknemers: 334
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ronald Renaud
CEO | Chief Executive Officer | 55 | 12-06-23 |
Director of Finance/CFO | 43 | 15-05-23 | |
N. Coles
CHM | Chairman | 63 | 01-12-18 |
Raymond Sanchez
CTO | Chief Tech/Sci/R&D Officer | 63 | 01-01-19 |
John Renger
CTO | Chief Tech/Sci/R&D Officer | 55 | 01-05-19 |
53 | - | ||
Matthew Calistri
IRC | Investor Relations Contact | - | - |
Scott Akamine
LAW | General Counsel | 40 | 24-05-21 |
Mark Bodenrader
AUD | Comptroller/Controller/Auditor | 51 | 01-09-19 |
Paul Burgess
PRN | Corporate Officer/Principal | 50 | 20-06-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 63 | 01-06-19 | |
Douglas Giordano
BRD | Director/Board Member | 61 | 01-09-18 |
Ruth McKernan
BRD | Director/Board Member | 66 | 04-12-20 |
Deval Patrick
BRD | Director/Board Member | 67 | 20-01-21 |
Marijn Dekkers
BRD | Director/Board Member | 65 | 01-09-18 |
Norbert Riedel
BRD | Director/Board Member | 66 | 01-12-18 |
N. Coles
CHM | Chairman | 63 | 01-12-18 |
Ronald Renaud
CEO | Chief Executive Officer | 55 | 12-06-23 |
Director/Board Member | 51 | 01-09-18 | |
Deborah Baron
BRD | Director/Board Member | 55 | 20-01-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 181 576 482 | 76 702 134 ( 42,24 %) | 0 | 42,24 % |
Bedrijfsgegevens
Cerevel Therapeutics Holdings, Inc.
222 Jacobs Street Suite 200
02141, Cambridge
+844 304 2048
http://www.cerevel.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,61% | 7,65 mld. | |
-3,30% | 102 mld. | |
+1,79% | 96,07 mld. | |
-0,44% | 21,66 mld. | |
-18,35% | 20,77 mld. | |
-7,45% | 18,53 mld. | |
-40,31% | 16,91 mld. | |
-26,84% | 13,79 mld. | |
+0,59% | 13,33 mld. | |
+20,86% | 10,94 mld. |
- Beurs
- Aandelen
- Koers CERE
- Onderneming Cerevel Therapeutics Holdings, Inc.